The identification of new prognostic factors able to stratify hepatocellular carcinoma patients candidate to first-line therapy is urgent. In the present work we validated the prognostic value of the lenvatinib prognostic index.
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib / Rimini, M., Kang, W., Burgio, V., Persano, M., Aoki, T., Shimose, S., Tada, T., Kumada, T., Sho, T., Lai, E., Celsa, C., Campani, C., Tonnini, M., Tamburini, E., Hiraoka, A., Takaguchi, K., Nishida, N., Iwamoto, H., Itobayashi, E.i., Tsuji, K., et al.. - In: HEPATOLOGY RESEARCH. - ISSN 1386-6346. - STAMPA. - 52:(2022), pp. 1050-1059. [10.1111/hepr.13824]
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib
Campani, Claudia;Marra, Fabio;
2022
Abstract
The identification of new prognostic factors able to stratify hepatocellular carcinoma patients candidate to first-line therapy is urgent. In the present work we validated the prognostic value of the lenvatinib prognostic index.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Hepatology Research - 2022 - Rimini - Validation of the easy‐to‐use lenvatinib prognostic index to predict prognosis in.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
473.67 kB
Formato
Adobe PDF
|
473.67 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
